Offstream
news

South Korea authorizes the emergency use of the anti-viral oral drug Paxlovid manufactured by Pfizer for high-risk patients over the age of 12 years, becoming the first drug to be approved for use in the country.
2021-12-27

Russia authorizes Pfizer to conduct clinical trials for its experimental COVID-19 drug named Paxlovid, which will continue until March 2023.
2021-11-16

Rady Children's Hospital in San Diego administers the first vaccines to children between the ages of 5 and 11 years old after Pfizer's COVID-19 vaccine was approved for use in children by the U.S. CDC.
2021-11-3

Switzerland signs an agreement with Pfizer to supply a total of 14 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 and 2023, which also includes an option to supply an additional 7 million vaccine doses in subsequent years.
2021-08-25

A study from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant, while the AstraZeneca–Oxford vaccine is 92% effective.
2021-06-14

Kosovo signs an agreement with Pfizer to buy 1.2 million doses of the Pfizer–BioNTech vaccine, with the vaccine rollout expected to begin on June 15.
2021-05-28

The World Health Organization lists the Pfizer-BioNTech vaccine for emergency use.
2020-12-31

Oman officially begins a vaccination campaign against COVID-19 using the Pfizer-BioNTech vaccine. The country is the last Gulf Cooperation Council member state to begin vaccinations. Health Minister Ahmed Al-Saidi is one of the first citizens to receive a dose of the vaccine.
2020-12-27

American company Pfizer and German company BioNTech announce that their vaccine could be ready for approval mid-October or early November.
2020-09-8

American company Pfizer and German company BioNTech say that they are on track to being submitted for regulatory review as early as October.
2020-08-21